Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasms
Gabriel Antherieu(Hospices Civils de Lyon), Maël Heiblig(Université Claude Bernard Lyon 1), Marie Balsat(Hôpital Claude Huriez), Christophe Nougier(Hospices Civils de Lyon), Vincent Alcazer(Lyon 1 Université), Anne-Marie Daull(Hospices Civils de Lyon), Yesim Dargaud(Université Claude Bernard Lyon 1), Sandrine Loron(Hôpital de la Croix-Rousse), Marie-Odile Geay-Baillat(Hospices Civils de Lyon), Fiorenza Barraco(Hôpital Lyon Sud), Marie‐Virginie Larcher, Hervé Ghesquières(Université Claude Bernard Lyon 1), Gaëlle Fossard(Hospices Civils de Lyon), Hamdi Rezigue(Université Claude Bernard Lyon 1), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Zofia Gross(Hospices Civils de Lyon), Hélène Labussière‐Wallet, Lila Gilis(Hospices Civils de Lyon)
Cited by 1
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309